Dogwood Therapeutics, Inc. Accrued Vacation, Current
Dogwood Therapeutics, Inc. (DWTX) had Accrued Vacation, Current of $49.37 thousand as of 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedVacationCurrent · last filed 2024-11-08
- 2024-09-30: Accrued Vacation, Current $49.37K.
- 2024-06-30: Accrued Vacation, Current $55.92K.
- 2024-03-31: Accrued Vacation, Current $93.97K.
| Period end | Accrued Vacation, Current |
|---|---|
| 2024-09-30 | $49.37K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $55.92K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $93.97K 10-Q · filed 2024-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |